Aggressive lobbying keeps seniors on Lucentis, prevents Medicare savings, Usa Today article states

Lobbying efforts have ensured that long-term care residents and other seniors are commonly prescribed the expensive drug Lucentis, even though the less costly drug Avastin has proven equally effective, suggested a USA TODAY article published Thursday.

http://ift.tt/1itsaZL